226 related articles for article (PubMed ID: 25921122)
1. 2-deoxy-D-Glucose Synergizes with Doxorubicin or L-Buthionine Sulfoximine to Reduce Adhesion and Migration of Breast Cancer Cells.
Mustafa EH; Mahmoud HT; Al-Hudhud MY; Abdalla MY; Ahmad IM; Yasin SR; Elkarmi AZ; Tahtamouni LH
Asian Pac J Cancer Prev; 2015; 16(8):3213-22. PubMed ID: 25921122
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel combined with inhibitors of glucose and hydroperoxide metabolism enhances breast cancer cell killing via H2O2-mediated oxidative stress.
Hadzic T; Aykin-Burns N; Zhu Y; Coleman MC; Leick K; Jacobson GM; Spitz DR
Free Radic Biol Med; 2010 Apr; 48(8):1024-33. PubMed ID: 20083194
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of glutamate cysteine ligase activity sensitizes human breast cancer cells to the toxicity of 2-deoxy-D-glucose.
Andringa KK; Coleman MC; Aykin-Burns N; Hitchler MJ; Walsh SA; Domann FE; Spitz DR
Cancer Res; 2006 Feb; 66(3):1605-10. PubMed ID: 16452219
[TBL] [Abstract][Full Text] [Related]
4. 2-Deoxy-D-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells.
Simons AL; Ahmad IM; Mattson DM; Dornfeld KJ; Spitz DR
Cancer Res; 2007 Apr; 67(7):3364-70. PubMed ID: 17409446
[TBL] [Abstract][Full Text] [Related]
5. Combined Treatment with 2-Deoxy-D-Glucose and Doxorubicin Enhances the in Vitro Efficiency of Breast Cancer Radiotherapy.
Islamian JP; Aghaee F; Farajollahi A; Baradaran B; Fazel M
Asian Pac J Cancer Prev; 2015; 16(18):8431-8. PubMed ID: 26745097
[TBL] [Abstract][Full Text] [Related]
6. Low-dose doxorubicin with carotenoids selectively alters redox status and upregulates oxidative stress-mediated apoptosis in breast cancer cells.
Vijay K; Sowmya PR; Arathi BP; Shilpa S; Shwetha HJ; Raju M; Baskaran V; Lakshminarayana R
Food Chem Toxicol; 2018 Aug; 118():675-690. PubMed ID: 29920287
[TBL] [Abstract][Full Text] [Related]
7. Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis.
Lewis-Wambi JS; Kim HR; Wambi C; Patel R; Pyle JR; Klein-Szanto AJ; Jordan VC
Breast Cancer Res; 2008; 10(6):R104. PubMed ID: 19061505
[TBL] [Abstract][Full Text] [Related]
8. Glutathione peroxidase-1 overexpression prevents ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells.
Gouazé V; Mirault ME; Carpentier S; Salvayre R; Levade T; Andrieu-Abadie N
Mol Pharmacol; 2001 Sep; 60(3):488-96. PubMed ID: 11502879
[TBL] [Abstract][Full Text] [Related]
9. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
Kisara S; Furusawa S; Murata R; Ogata M; Hikichi N; Takayanagi Y; Sasaki K
Oncol Res; 1995; 7(3-4):191-200. PubMed ID: 8555653
[TBL] [Abstract][Full Text] [Related]
10. Combined inhibition of glycolysis, the pentose cycle, and thioredoxin metabolism selectively increases cytotoxicity and oxidative stress in human breast and prostate cancer.
Li L; Fath MA; Scarbrough PM; Watson WH; Spitz DR
Redox Biol; 2015; 4():127-35. PubMed ID: 25560241
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous inhibition of glutathione- and thioredoxin-dependent metabolism is necessary to potentiate 17AAG-induced cancer cell killing via oxidative stress.
Scarbrough PM; Mapuskar KA; Mattson DM; Gius D; Watson WH; Spitz DR
Free Radic Biol Med; 2012 Jan; 52(2):436-43. PubMed ID: 22100505
[TBL] [Abstract][Full Text] [Related]
12. Cyclophosphamide-induced apoptosis in COV434 human granulosa cells involves oxidative stress and glutathione depletion.
Tsai-Turton M; Luong BT; Tan Y; Luderer U
Toxicol Sci; 2007 Jul; 98(1):216-30. PubMed ID: 17434952
[TBL] [Abstract][Full Text] [Related]
13. Combination of Potassium Pentagamavunon-0 and Doxorubicin Induces Apoptosis and Cell Cycle Arrest and Inhibits Metastasis in Breast Cancer Cells.
Putri H; Jenie RI; Handayani S; Kastian RF; Meiyanto E
Asian Pac J Cancer Prev; 2016; 17(5):2683-8. PubMed ID: 27268651
[TBL] [Abstract][Full Text] [Related]
14. Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin.
Xue C; Wang C; Sun Y; Meng Q; Liu Z; Huo X; Sun P; Sun H; Ma X; Ma X; Peng J; Liu K
Oncotarget; 2017 Jan; 8(5):8622-8632. PubMed ID: 28052008
[TBL] [Abstract][Full Text] [Related]
15. The responses of Ht22 cells to oxidative stress induced by buthionine sulfoximine (BSO).
Chen J; Small-Howard A; Yin A; Berry MJ
BMC Neurosci; 2005 Feb; 6():10. PubMed ID: 15707499
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial DNA depletion promotes impaired oxidative status and adaptive resistance to apoptosis in T47D breast cancer cells.
Yu M; Shi Y; Wei X; Yang Y; Zang F; Niu R
Eur J Cancer Prev; 2009 Nov; 18(6):445-57. PubMed ID: 19609211
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine.
Yang B; Keshelava N; Anderson CP; Reynolds CP
Cancer Res; 2003 Apr; 63(7):1520-6. PubMed ID: 12670899
[TBL] [Abstract][Full Text] [Related]
18. Modulation of rat erythrocyte antioxidant defense system by buthionine sulfoximine and its reversal by glutathione monoester therapy.
Rajasekaran NS; Devaraj NS; Devaraj H
Biochim Biophys Acta; 2004 Mar; 1688(2):121-9. PubMed ID: 14990342
[TBL] [Abstract][Full Text] [Related]
19. The effects of buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on propyl gallate-treated HeLa cells in relation to cell growth, reactive oxygen species and glutathione.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Int J Mol Med; 2009 Aug; 24(2):261-8. PubMed ID: 19578799
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of buthionine sulfoximine on the chlorin e6-based photodynamic treatment of cancer cells.
Lee HM; Kim DH; Lee HL; Cha B; Kang DH; Jeong YI
Arch Pharm Res; 2019 Nov; 42(11):990-999. PubMed ID: 31482490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
